# Diagnostic Potential of Hypermethylated DNA in Colorectal Cancer

> **NCT02928120** · — · UNKNOWN · sponsor: **Ole Thorlacius-Ussing, MD, DMSc, Professor of Surgery** · enrollment: 658 (estimated)

## Conditions studied

- Colorectal Neoplasms
- Aberrant DNA Methylation

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02928120
- **Lead sponsor:** Ole Thorlacius-Ussing, MD, DMSc, Professor of Surgery
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-02
- **Primary completion:** 2017-09
- **Final completion:** 2018-09
- **Target enrollment:** 658 (ESTIMATED)
- **Last updated:** 2016-10-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02928120

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02928120, "Diagnostic Potential of Hypermethylated DNA in Colorectal Cancer". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT02928120. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*